Skip to main content

From drones to smart pills, 2018 saw significant tech advances in medicine

Ascom / MCTIC

Robots, A.I. algorithms, and drone deliveries are increasingly found in just about every industry and profession. Why not the medical world, too? To that end, 2018 saw an impressive convergence of cutting-edge technology and groundbreaking medical research.

It is, of course, crucial that any new technology is properly investigated before it finds its way to patients, but — when the right steps are taken — these tools can be a game changer when it comes to health and wellness. Here are some of the biggest medical tech stories that caught our eye this year.

Recommended Videos

Medical drone deliveries

We’re still not at the point where most of us can get a book or DVD (if people still buy those!) delivered by drone, but drone-based medical deliveries nonetheless made big strides in 2018.

A pioneering medical trial by the University of Maryland demonstrated that drones could be used for safely transporting a potentially lifesaving transplant organ. They did this by putting a kidney in a cooler and flying it underneath a DJI M600 Pro drone to see if it suffered any damage. It didn’t — and the organ actually experienced fewer vibrations than it would when being transported in a fixed-wing plane.

Zipline

Meanwhile, Zipline unveiled a new, faster drone for delivering vital medical services such as blood supplies. For the past two years, Zipline has delivered blood for vital transfusions to remote clinics in Rwanda. The company’s new drone — which it claims is the fastest commercial delivery drone around — will make this mission more efficient. It’s got its eye on offering similar services in the U.S., too.

Wonders (and blunders) of gene editing

2018 was a significant year for advances in CRISPR gene editing. Operating in animal (predominantly mice) models, researchers demonstrated how severe obesity, autism, Duchenne muscular dystrophy, dementia, cocaine addiction, and other conditions can potentially be treated with careful use of gene therapy.

While these advances were generally met with favorable responses from the scientific community, a reported experiment coming out of China most certainly was not.

In the most infamous “medical advance” of 2018, researchers in China reportedly delivered the world’s first twins who had been genetically altered as embryos to remove a gene associated with potentially fatal diseases such as HIV, smallpox, and cholera.

The news received immediate backlash and intense criticism from around the world. Provided that the report is accurate (details have been far from forthcoming), this nonetheless represents a major landmark. Just not a landmark many hoped would be reached without far more research.

Bioengineered tissues and organs

There’s a massive shortage of available transplant organs. One potential solution would be to be able to grow new ones in the lab. While we’re not yet at the point at which this is entirely possible, 2018 moved the research in the right direction. The field of 3D bioprinting continued to make strides through the demonstration of 3D-printed human cardiac tissue.

3D-printed prototype for bionic eye

One of the other significant advances from our perspective was the creation of bioengineered lungs at the University of Texas Medical Branch at Galveston. These were then successfully transplanted into pigs, allowing them to breathe normally with no medical complications.

Transferring that research to clinical trials for humans is likely to take another five to eight years of preclinical testing. It’s an important advance, however.

Smart pills

Our phones have been smart for a decade now, our watches for a bit less than that, and our homes are getting smarter all the time. Why not smart pills as well?

That’s what researchers from RMIT University in Melbourne, Australia, demonstrated this year with the creation of a functioning electronic capsule which, once swallowed, measures gas biomarkers as it travels through the gut. As it does this, it gathers information relating to food, gut environment, and more — before transmitting it out of the body to a smartphone or other device. It could be useful for diagnosing diseases from irritable bowel syndrome and inflammatory bowel disease to potentially fatal ones such as colon cancer.

While it’s not quite ready for prime time, researchers have completed a successful phase 1 trial on 26 healthy individuals, proving the capsules’ safety and efficacy. Another not dissimilar project — also from researchers in Australia — explores how the smart pill experience could be “gamified” for the benefit of users.

Medical robots

Medical robots are getting better all the time. This year, neurosurgeons and otolaryngologists at the University of Pennsylvania’s Perelman School of Medicine reported performing the world’s first robot-assisted spinal surgery. This complex procedure involved the use of robot arms to remove a tumor from the neck of a 27-year-old patient.

Pediatric HAL®: The World's Most Advanced Pediatric Patient Simulator

For the procedure, neurosurgeons entered the patient’s body through the neck and cut the spine around the tumor. A team of three (human) surgeons then utilized the surgical robot to remove the tumor through the patient’s mouth. The spinal column was then reconstructed, using a hip bone and additional rods for stability.

“There are two components that make this work so exciting,” Dr. Neil Malhotra, one of the surgeons involved in the procedure, told Digital Trends. “One is that it permits us to switch from palliation for certain types of tumors to, in some cases for the first time, seeking cures. For the second point, this approach is less traumatic for the patient, which means a better recovery.”

Algorithm that predict mortality

No, no one in their right mind is suggesting replacing flesh-and-blood doctors with algorithms. However, machine learning tools definitely have their predictive place in modern medicine. With that in mind, the U.S. Food and Drug Administration this year granted its clearance for an algorithm that’s used in hospitals to help predict (and, hopefully, prevent) sudden patient deaths.

The Wave Clinical Platform works by monitoring patients’ vital signs and sending alerts warning about impending heart attacks or respiratory failure up to six hours before a patient suffers such an event. What makes the system so smart is that it not only monitors multiple biometrics for patients, but analyzes these in conjunction with one another. For example, a minor decrease in a patient’s respiratory rate wouldn’t usually be enough to trigger an emergency call. But if it’s accompanied by a spike in blood pressure, this could suggest something far more worrying.

A clinical trial among elderly patients at the University of Pittsburgh Medical Center showed that a group using the technology experienced fewer unexpected deaths than those who did not.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
BYD’s cheap EVs might remain out of Canada too
BYD Han

With Chinese-made electric vehicles facing stiff tariffs in both Europe and America, a stirring question for EV drivers has started to arise: Can the race to make EVs more affordable continue if the world leader is kept out of the race?

China’s BYD, recognized as a global leader in terms of affordability, had to backtrack on plans to reach the U.S. market after the Biden administration in May imposed 100% tariffs on EVs made in China.

Read more
Tesla posts exaggerate self-driving capacity, safety regulators say
Beta of Tesla's FSD in a car.

The National Highway Traffic Safety Administration (NHTSA) is concerned that Tesla’s use of social media and its website makes false promises about the automaker’s full-self driving (FSD) software.
The warning dates back from May, but was made public in an email to Tesla released on November 8.
The NHTSA opened an investigation in October into 2.4 million Tesla vehicles equipped with the FSD software, following three reported collisions and a fatal crash. The investigation centers on FSD’s ability to perform in “relatively common” reduced visibility conditions, such as sun glare, fog, and airborne dust.
In these instances, it appears that “the driver may not be aware that he or she is responsible” to make appropriate operational selections, or “fully understand” the nuances of the system, NHTSA said.
Meanwhile, “Tesla’s X (Twitter) account has reposted or endorsed postings that exhibit disengaged driver behavior,” Gregory Magno, the NHTSA’s vehicle defects chief investigator, wrote to Tesla in an email.
The postings, which included reposted YouTube videos, may encourage viewers to see FSD-supervised as a “Robotaxi” instead of a partially automated, driver-assist system that requires “persistent attention and intermittent intervention by the driver,” Magno said.
In one of a number of Tesla posts on X, the social media platform owned by Tesla CEO Elon Musk, a driver was seen using FSD to reach a hospital while undergoing a heart attack. In another post, a driver said he had used FSD for a 50-minute ride home. Meanwhile, third-party comments on the posts promoted the advantages of using FSD while under the influence of alcohol or when tired, NHTSA said.
Tesla’s official website also promotes conflicting messaging on the capabilities of the FSD software, the regulator said.
NHTSA has requested that Tesla revisit its communications to ensure its messaging remains consistent with FSD’s approved instructions, namely that the software provides only a driver assist/support system requiring drivers to remain vigilant and maintain constant readiness to intervene in driving.
Tesla last month unveiled the Cybercab, an autonomous-driving EV with no steering wheel or pedals. The vehicle has been promoted as a robotaxi, a self-driving vehicle operated as part of a ride-paying service, such as the one already offered by Alphabet-owned Waymo.
But Tesla’s self-driving technology has remained under the scrutiny of regulators. FSD relies on multiple onboard cameras to feed machine-learning models that, in turn, help the car make decisions based on what it sees.
Meanwhile, Waymo’s technology relies on premapped roads, sensors, cameras, radar, and lidar (a laser-light radar), which might be very costly, but has met the approval of safety regulators.

Read more
Waymo, Nexar present AI-based study to protect ‘vulnerable’ road users
waymo data vulnerable road users ml still  1 ea18c3

Robotaxi operator Waymo says its partnership with Nexar, a machine-learning tech firm dedicated to improving road safety, has yielded the largest dataset of its kind in the U.S., which will help inform the driving of its own automated vehicles.

As part of its latest research with Nexar, Waymo has reconstructed hundreds of crashes involving what it calls ‘vulnerable road users’ (VRUs), such as pedestrians walking through crosswalks, biyclists in city streets, or high-speed motorcycle riders on highways.

Read more